Skip to search boxSkip to navigationSkip to main content

Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy

  • ,
  • J. Zhou
    ,
  • A. W. Minto
    ,
  • B. K. Hack
    ,
  • J. J. Alexander
    ,
  • M. Haas
*Corresponding author for this work
  • The University of Chicago
    ,
  • Johns Hopkins University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>The db/db mouse develops features of type II diabetes mellitus as the result of impaired signaling through its abnormal leptin receptor. In spite of accurate metabolic features of diabetes, renal disease manifestations in these mice are not as severe as in humans suggesting the presence of protective genes. There is a growing body of evidence in humans for the relevance of vitamin D in diabetes. Here we followed a large cohort of db/db mice and their non-diabetic db/+ littermates. Transcriptional profiling revealed significant upregulation of 23 genes involved in Ca<sup>2+</sup> homeostasis and vitamin D metabolism in db/db glomeruli relative to db/+ glomeruli. Increased glomerular expression of vitamin D<sub>3</sub> 1α-hydroxylase, vitamin D binding protein, calbindins D9K and D28K, and calcyclin mRNA was confirmed by quantitative reverse transcription-polymerase chain reaction in 20-, 36-, and 52-week-old db/db glomeruli. Although vitamin D<sub>3</sub> 1α-hydroxylase protein was primarily expressed and upregulated in db/db renal tubules, it was also expressed in glomerular podocytes in vivo. Serum 1,25-dihydroxyvitamin D <sub>3</sub> and urinary Ca<sup>2+</sup> excretion were increased >3-fold in db/db mice compared to db/+ mice. Cultured glomerular podocytes had mRNA for vitamin D<sub>3</sub> 1α-hydroxylase, vitamin D receptor, and calbindin D28K, each of which was increased in high glucose conditions. High glucose also led to enhanced production of fibronectin and collagen IV protein, which was blocked by 1,25-dihydroxyvitamin D<sub>3</sub>. These results show that vitamin D metabolism is altered in db/db mice leading to metabolic and transcriptional effects. The podocyte is affected by paracrine and potentially autocrine effects of vitamin D, which may explain why db/db mice are resistant to progressive diabetic nephropathy.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 882-891 (10 pages)

Journal (Volume, Issue Number)

Kidney International (Volume 70, Issue 5)

Publication milestones

  • Published - 09/28/2006

Publication status

Published - 09/28/2006

ISSN

0085-2538

Publication IDs

  • Scopus: 33747867785
  • PubMed: 16820793

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
SciVal
FWCI
1.31
SciVal
Author count
9
SciVal
citations
61
SciVal
Paper percentile
90
SciVal
Top percentile
10

PlumX, opens in new tab

Citation count
65
Captures
34

Funding Details

This work was supported by National Institutes of Health Grants R01DK41873 and R21DK57684 to RJQ, R01DK59327 to YCL, and U01DK60994 (Animal Models of Diabetic Complications Consortium) to CWH.
FundersFunding numbers
NIH
R01DK59327, R21DK57684, U01DK60994
NIDDK
R01DK041873